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LIVER FAILURE/CIRRHOSIS/PORTAL HYPERTENSION

Liver Injury in Acute Fatty Liver of Pregnancy:
Possible Link to Placental Mitochondrial Dysfunction
and Oxidative Stress
Sathish Kumar Natarajan,1 Kavitha R. Thangaraj,1 C. E. Eapen,1 Anup Ramachandran,1 Ashis Mukhopadhya,1
Mathews Mathai,2 Lakshmi Seshadri,2 Abraham Peedikayil,2 Banumathi Ramakrishna,3 and
Kunnissery A. Balasubramanian1*
Acute fatty liver of pregnancy (AFLP) is a rare disorder which is fatal if not recognized and treated
early. Delivery of the feto-placental unit results in dramatic improvement in maternal liver function,
suggesting a role for the placenta. However, the mechanisms by which defects in the fetus or placenta
lead to maternal liver damage are not well understood and form the focus of this study. Placenta and
serum were obtained at delivery from patients with AFLP, and placental mitochondria and peroxisomes were isolated. Placental mitochondrial function, oxidative stress, and fatty acid composition as
well as serum antioxidants, oxidative and nitrosative stress markers, and fatty acid analysis were carried
out. Hepatocytes in culture were used to evaluate cell death, mitochondrial function, and lipid accumulation on exposure to fatty acids. Oxidative stress was evident in placental mitochondria and
peroxisomes of patients with AFLP, accompanied by compromised mitochondrial function. Increased levels of arachidonic acid were also seen in AFLP placenta when compared to control. Patients
with AFLP also had a signiﬁcant increase in oxidative and nitrosative stress markers in serum, along
with decreased antioxidant levels and elevated levels of arachidonic acid. These levels of arachidonic
acid were capable of inducing oxidative stress in hepatocyte mitochondria accompanied by induction
of apoptosis. Exposure to arachidonic acid also resulted in increased lipid deposition in hepatocytes.
Conclusion: Oxidative stress in placental mitochondria and peroxisomes is accompanied by accumulation of toxic mediators such as arachidonic acid, which may play a causative role in maternal liver
damage seen in AFLP. (HEPATOLOGY 2010;51:191–200.)

A

cute fatty liver of pregnancy (AFLP) is an example
of a primary mitochondrial hepatopathy1 characterized by hepatic microvesicular steatosis, hepatic
failure, and encephalopathy developing in the last trimes-
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ter of pregnancy.2,3 Although the majority of primary
mitochondrial hepatopathies present in childhood, AFLP
presents in a previously asymptomatic woman in late
pregnancy. The disease is associated with defects in ␤-oxidation of fatty acids in mitochondria4 especially the mitochondrial long-chain acyl coenzyme A dehydrogenase
(LCHAD)5,6 in the fetus, but it is now recognized that
AFLP can occur without a mutation in LCHAD.7,8 This
suggests that the metabolic basis of AFLP is more heterogeneous than believed earlier, but the mechanism by
which a fetal defect in lipid metabolism causes maternal
liver damage is not well understood. Interestingly, it has
been observed that patients with AFLP generally recover
from liver dysfunction subsequent to delivery of the fetus,9 suggesting a causative role for the placenta, which is
expelled during delivery.
During gestation, the placenta is essential for fetal development and utilizes fatty acids as a signiﬁcant metabolic fuel.10 The genetic composition of the placenta is
identical to that of the fetus, and all enzymes of the mitochondrial fatty acid ␤-oxidation pathway are expressed
and active in human placenta,11 with activities being maximum in the second trimester and decreasing with gesta191
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tional age in the third trimester.4 It is also recognized that
placental fatty acid metabolism can play a critical role in
guiding pregnancy and fetal outcome.12 Defects in transport of fatty acids into the mitochondria or blocks at any
other steps of ␤-oxidation could lead to accumulation of
fatty acids and their metabolic products,13 which could be
toxic.
Oxidative stress has been implicated in a number of
liver diseases, and earlier work from our laboratory demonstrated that experimental hepatic microvesicular steatosis results in mitochondrial dysfunction and oxidative
stress in liver subcellular organelles.14 Oxidative stress has
been demonstrated in patients with preeclampsia,15 a
condition seen in 40% of patients with AFLP.16 Mitochondria are an important cellular source of free radicals,
and placental mitochondria have been implicated in free
radical generation in patients with preeclampsia.17 Another cellular source of free radicals in relation to fatty
acid oxidation would be peroxisomes, where ␤-oxidation
of fatty acids can result in generation of these active species.18
Based on the dramatic improvement in maternal liver
function on delivery and the fact that the mother preferentially uses fatty acids as the predominant energy source
in late pregnancy,19 we hypothesized that compromised
fatty acid metabolism in placental mitochondria of patients with AFLP would result in generation of oxidative
stress in mitochondria and peroxisomes with production
of toxic intermediates of fatty acid oxidation. These compounds could then spill over into the maternal circulation
and result in hepatotoxicity. This hypothesis was tested by
evaluation of oxidative stress in serum as well as analysis of
placental mitochondria and peroxisomes from patients
with AFLP in comparison with controls.

Patients and Methods
Adenosine diphosphate; dimethyl sulfoxide; 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyltetrazolium bromide
(MTT); 1,1⬘, 3,3⬘-tetramethoxy propane, Tris(hydroxymethyl) aminomethane (Tris); thiobarbituric acid;
dithio-bis-(2-nitrobenzoic acid); 2,4-dinitrophenyl hydrazine; arsenazo III; succinic acid; 2-(p-iodophenyl)-3-(pnitrophenyl)-5-phenyl tetrazolium; bovine serum albumin;
arachidonic acid; caspase-3 substrate (AC-DEVD-pNA); dithiothreitol; dihydrorhodamine (DHR); Nile red; and paranitrophenyl phosphate were obtained from Sigma Chemical
Co. (St. Louis, MO). All other chemicals and solvents used
were of analytical grade.
Patients. Seven patients with AFLP diagnosed as per
clinical diagnostic criteria20 were recruited for the study,
after obtaining informed consent. Five of these patients
underwent liver biopsy and had hepatic microvesicular
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steatosis (Fig. 1), which conﬁrmed the diagnosis of AFLP
in these patients. All seven patients had negative hepatitis
A, B, C, and E serology. None of the AFLP patients were
obese. Controls were 10 mothers matched for gestational
age, who underwent normal delivery at the hospital. Both
controls and AFLP patients were from the lower socioeconomic category. This study was approved by the Institutional Experimentation Ethics Committee.
Isolation of Subcellular Organelles. Human placentas were processed within 30 minutes of delivery. The
blood was drained and placental tissue was minced and
washed three times with a buffer containing 250 mM
sucrose, 1 mM Tris, and 1 mM ethylene diamine tetraacetic acid (EDTA; pH 7.4). The washed mince was ﬁltered
through two layers of surgical gauze and homogenized
with four volumes of buffer containing 250 mM sucrose,
1 mM Tris, 1 mM EDTA, pH 7.4. The homogenate was
centrifuged at 1500g for 15 minutes and mitochondria
were pelleted at 16,000g for 10 minutes and washed twice
with mitochondrial suspension buffer containing 250
mM sucrose, 1 mM Tris HCl (pH 7.4).21 Postmitochondrial supernatant was then centrifuged at 39,000g for 10
minutes to isolate the fraction including peroxisomes,
which was resuspended in 250 mM sucrose containing 1
mM EDTA and 1 mM Tris HCl (pH 7.4). This suspension was again centrifuged at 16,000g for 10 minutes to
remove mitochondrial contamination and the supernatant was then centrifuged at 39,000g for obtaining peroxisomal fraction. Purity of the isolated mitochondria and
peroxisomes was checked by enrichment of marker enzymes succinate dehydrogenase and catalase,14 respectively.
Assessment of Placental Mitochondrial Function.
Mitochondrial function was assessed by measuring oxygen uptake, mitochondrial swelling, MTT reduction, and
calcium ﬂux measurements. Oxygen uptake was determined polarographically using a Clark-type electrode in 3
mL respiration medium (150 mM sucrose, 1 mM
KH2PO4, 10 mM Tris, 5 mM MgCl2, 20 mM KCl [pH
7.4]) containing 5 mM succinate as respiratory substrate.
A mitochondrial protein of 1-2 mg/mL was used. Oxygen
uptake during both state 3 (in presence of adenosine
diphosphate and succinate) and state 4 (in presence of
succinate alone) respiration were measured and the ratio
of state 3/state 4 respiratory rate was used to calculate the
respiratory control ratio.22 A mitochondrial protein corresponding to 100-200 g in suspension buffer was used
to determine mitochondrial swelling by measuring the
decrease in absorbance at 540 nm up to 7 minutes. To
determine the exclusive effect of AFLP on placental mitochondrial swelling without additional stimuli, no external inducers such as calcium or oxidative stress were

HEPATOLOGY, Vol. 51, No. 1, 2010

NATARAJAN ET AL.

193

Respiratory Control Ratio

A
2.5
2

B

1.5

*

1
0.5

C

2
1.5
1
0.5
0

CONTROL

300

D

*

100
0

CONTROL

CONTROL

AFLP

Calcium

AFLP

200

E
0.146

AFLP

0.0015
Calcium flux

0.144
Absorbance

Fig. 1. (A) Liver biopsy showing
microvesicular steatosis in the perivenular region. (B-E) Mitochondrial function in placenta. (B) Respiratory
control ratio, (C) mitochondrial swelling, (D) MTT reduction, (E) a representative trace from calcium ﬂux
measurements, and (F) quantitative
assessment of calcium efﬂux in placental mitochondria isolated from patients with AFLP (n ⫽ 7), when
compared with healthy pregnant controls (n ⫽ 10). The assays were done
as described in the text. Each value
represents mean ⫾ SD. * P ⬍ 0.05,
when compared to control.
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applied in these experiments. The data is expressed as
change in absorbance per minute per mg protein.23 The
MTT reduction assay was performed using a microplate
reader as described.24 Calcium ﬂux measurement was
done by quantitation of changes in the absorption spectrum of Arsenazo III at 675/685 nm. Arsenazo III is an
impermeable dye that indicates calcium concentration
outside mitochondria. On addition of exogenous calcium
to a suspension of mitochondria, there is an initial increase in absorbance due to binding of calcium to the dye.
However, this is a dynamic process, and as the mitochondria take up calcium through the uniporter, there is a
decrease in external concentrations of calcium, reﬂected
in a decrease in absorbance. Mitochondria were suspended in a medium containing 230 mM mannitol, 70
mM sucrose, 5 mM HEPES, 5 mM succinate, and 40 M
Arsenazo III (pH 7.4). A concentration of 10 M calcium
was added to the reaction medium to initiate the ﬂux
studies.25

10

Measurement of Oxidative Stress Markers. Malondialdehyde was measured using the thiobarbituric acid
method.26 For conjugated diene measurements, total lipids were extracted, dissolved in 1 mL heptane, read at 233
nm and expressed as nmoles per milligram protein using a
molar absorption coefﬁcient of 2.52 ⫻ 104. Protein carbonyl content formed was measured using 2,4-dinitrophenyl hydrazine and calculated using an extinction
coefﬁcient of 22 mM⫺1 cm⫺1.27 Protein thiol and total
thiol content were measured using dithio-bis-(2-nitrobenzoic acid) and expressed as nanomoles per milligram
protein.28 Protein was estimated by Lowry’s method using bovine serum albumin as a standard.29
Enzyme Assays. Catalase activity was estimated by
measuring the change in absorbance at 240 nm using
hydrogen peroxide as substrate and expressed as units per
milligram protein30 (units are expressed as micromoles
per minute). Succinate dehydrogenase activity was assayed using 2-(p-iodophenyl)-3-(p-nitrophenyl)-5-phe-
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nyl tetrazolium as an electron acceptor, which forms
formazan crystals on reduction. Data is expressed as units
per milligram protein.31
Serum Retinol and Tocopherol Extraction and
Quantitation by High-Performance Liquid Chromatography. For analysis, 0.5 mL serum was mixed with
equal volume of ethanol and hexane. Retinol and tocopherol were extracted three times by a triple volume of hexane. Extracted fractions were dried under nitrogen and
reconstituted in methanol:diethyl ether (3:1), followed by
separation and quantitation by high-performance liquid
chromatography.32 The recovery of retinol and tocopherol by this method was around 95%.
Measurement of Free Fatty Acids. Serum and placental homogenate lipids were extracted by the Bligh and
Dyer method33 and the lower organic phase was concentrated using nitrogen, resuspended in a small volume of
chloroform:methanol (2:1), and used for lipid analysis.
Neutral lipids were separated on silica gel G plates using
the solvent system hexane:diethyl ether:acetic acid (80:
20:1, vol/vol). Spots corresponding to the standard were
identiﬁed by iodine exposure and eluted. Fatty acid content was quantitated using gas chromatography as described.34
Cell Culture and Arachidonic Acid Treatment.
The Chang hepatocyte cell line is a well-differentiated
nonmalignant liver epithelial cell line of human origin.35,36 Cells were maintained (37°C, 5% CO2) in a
growth medium (Dulbecco’s modiﬁed Eagle medium;
Gibco) containing 10% fetal bovine serum (Gibco), penicillin (100 units/mL), streptomycin (100 g/mL), and
amphotericin-B (250 g/mL; Gibco). For experiments
measuring reactive oxygen species and apoptosis with arachidonic acid, conﬂuent cells were treated with various
concentrations of arachidonic acid (20-100 M) for 3
hours.
Caspase Assay. For detection of caspase-3 activity,
hepatocytes were lysed in buffer (0.15 M NaCl, 5 mM
EDTA, 1% Triton X, 10 mM Tris HCl [pH 7.4]).
Caspase-3 activity was detected in cell lysates by measuring the proteolytic cleavage of the colorimetric substrate
acetyl-Asp-Glu-Val-Asp (DEVD)-pNA in assay buffer
(100 mM HEPES, 10% sucrose, 0.1% CHAPS [{3-[(3cholamidopropyl)dimethylammonio]-1-propanesulfonate}; pH 7.5], 1 mM phenylmethylsulfonyl ﬂuoride and
10 mM dithiothreitol) using the absorbance of released
para-nitroanilide at a wavelength of 405 nm.
Measurement of Mitochondrial Reactive Oxygen
Species Generation in Hepatocytes. Mitochondrial reactive oxygen species generation in cultured cells was measured by oxidation of DHR 123 to rhodamine 123. For
live-cell microscopy, cells were grown in 96-well plates
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Table 1. Clinical Details of the Patients and Controls
Details

Control (n ⴝ 10)

AFLP (n ⴝ 7)

Age
Gestational age (weeks)
Total bilirubin (mg%)
Direct bilirubin (mg%)
Total protein (g%)
Albumin (g%)
AST (U/L)
ALT (U/L)
ALP (U/L)
Prothrombin time-INR

25 ⫾ 3
39 ⫾ 1
0.5 ⫾ 0.2
0.2 ⫾ 0.07
6.3 ⫾ 1
3.2 ⫾ 0.6
17.2 ⫾ 4.2
12.3 ⫾ 3
177 ⫾ 67
0.92 ⫾ 0.04

29 ⫾ 4
34 ⫾ 1
12 ⫾ 6*
10.5 ⫾ 5.7*
5.4 ⫾ 1
2.4 ⫾ 0.2*
166 ⫾ 66*
131 ⫾ 71*
454 ⫾ 266*
2.25 ⫾ 0.6*

*P ⬍ 0.001, when compared to controls.

and incubated with various concentrations of arachidonic
acid for 3 hours in the presence of 10 M DHR. At the
end of incubation, cells were washed with phosphatebuffered saline and imaged on an inverted ﬂuorescent
microscope (Zeiss Axiovert 200M) using a rhodamine
ﬁlter. Quantitation of rhodamine ﬂuorescence was carried
out in parallel experiments, where cells were lysed with
lysis buffer (0.15 M NaCl, 5 mM EDTA, 1% Triton X,
10 mM Tris HCl [pH 7.4]) after incubation with arachidonic acid. Rhodamine 123 ﬂuorescence was then measured at an excitation of 500 nm and emission of 536 nm
on a spectrophotometer. The measured ﬂuorescence
value was expressed as a fold change compared to that of
untreated control.
Measurement of Lipid Accumulation in Hepatocytes. Lipid staining with the benzophenoxazone dye
Nile red was performed as follows: A stock solution of
Nile red (1 mg/mL in dimethyl sulfoxide) was prepared
and 1:1000 working dilution was used for staining cells.
Hepatocytes in culture were treated with 20 and 40 M
arachidonic acid for 3 days, following which cells were
treated with Nile red for 90 minutes. Cell nuclei was
stained with Hoechst 33258, and imaged on an inverted
ﬂuorescent microscope using the rhodamine ﬁlter.
Statistical Analysis. Data are expressed as mean ⫾
standard deviation (SD). Statistical analysis was performed with the nonparametric Mann-Whitney test.
Standard calculations were performed using SPSS software (version 9.0).

Results
Clinical details for patients enrolled in the study are
shown in Table 1. No differences were noted in the mean
age between the two groups. Signiﬁcant increase in total
and direct bilirubin as well as aspartate aminotransferase,
alanine aminotransferase, alkaline phosphatase, and prothrombin time, accompanied by a decrease in serum albumin were noted in patients with AFLP. Microvesicular
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Fig. 2. Oxidative stress parameters: (A) malondialdehyde, (B) conjugated diene, (C) protein carbonyl content, and (D) total thiol in
placental mitochondria isolated from patients
with AFLP (n ⫽ 7), when compared with
healthy pregnant controls (n ⫽ 10). The assays
were done as described in the text. Each value
represents mean ⫾ SD. *P ⬍ 0.05, when
compared to control.

20

CONTROL

*

15
10
5
0

CONTROL

Conjugated diene
(nmoles/mg protein)

*

150
100
50
0

30

CONTROL

AFLP

D
*

20
10
0

CONTROL

AFLP

protein carbonyl concentration (Fig. 2C) along with a
decrease in thiol content (Fig. 2D) in placental mitochondria isolated from patients with AFLP, suggesting oxidative stress.
Compromised mitochondrial function can lead to shunting of fatty acids to peroxisomal ␤-oxidation, and concomitant generation of reactive oxygen species.18 To determine if
this resulted in oxidative stress in peroxisomes, these were
isolated from placenta in patients with AFLP and markers of
oxidative stress were examined. An increase in malondialdehyde, conjugated diene, and protein carbonyl levels accompanied by a decrease in thiol content is evident in placental
peroxisomes isolated from patients with AFLP when compared to pregnant controls (Fig. 3).
Impaired fatty acid oxidation could lead to an accumulation of fatty acids in the placenta. To determine if this
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steatosis in the perivenular region was also evident on liver
biopsy (Fig. 1A).
Impaired fatty acid metabolism has been suggested to
play a role in the etiology of the disease and because mitochondria play a central role in fatty acid metabolism,
initial experiments examined functional parameters in the
placental mitochondria and the role of oxidative stress. A
decrease in respiratory control ratio (Fig. 1B), along with
increased mitochondrial swelling (Fig. 1C) and MTT reduction (Fig. 1D) as well as altered calcium ﬂux (Fig.
1E,F), were seen in placental mitochondria isolated from
AFLP patients as compared to controls. The calcium ﬂux
measurement shown in Fig. 1E is a representative experiment done in triplicate. Examination of oxidative stress
parameters revealed a signiﬁcant increase in malondialdehyde levels (Fig. 2A), conjugated diene (Fig. 2B), and
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Fig. 3. Oxidative stress parameters: (A) malondialdehyde, (B) conjugated diene, (C) protein carbonyl content, (D) and total thiol in
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Fig. 4. Measurement of free fatty acids in placenta. (A) Arachidonic
acid, (B) palmitic acid, (C) oleic acid, and (D) myristic acid from patients
with AFLP (n ⫽ 7), when compared with healthy pregnant controls (n ⫽
10). The assays were done as described in the text. Each value represents mean ⫾ SD. *P ⬍ 0.05, when compared to controls

was occurring, the levels of various fatty acids in placental
tissue from patients with AFLP were analyzed. A signiﬁcant increase in arachidonic, palmitic, oleic, and myristic
acids was seen in placenta from patients with AFLP as
compared to controls (Fig. 4).
The next series of experiments evaluated the levels of
serum antioxidants and oxidative and nitrosative stress
markers in maternal systemic circulation. Analysis of oxidative stress parameters in the serum from patients with
AFLP demonstrated a signiﬁcant increase in malondialdehyde and protein carbonyl content when compared to
controls, indicating extensive lipid peroxidation and protein oxidation (Fig. 5A,B). This increase in oxidative
stress markers was associated with a concomitant decrease
in protein thiols (Fig. 5C). A signiﬁcant increase in the
levels of serum nitrate (Fig. 5D), the stable end product of
nitric oxide, was also evident in serum from patients with
AFLP, indicating nitrosative stress as well. These changes

were accompanied by a decrease in antioxidants such as
retinol and tocopherol (Fig. 5E,F). Fatty acid analysis
in serum demonstrated a signiﬁcant increase in arachidonic acid and palmitic acid in patients with AFLP
(Fig. 6A,B).
It has been demonstrated earlier that exposure to arachidonic acid can induce apoptosis in Hep G2 hepatocytes37 by a mechanism dependent on oxidative stress.38
The next series of experiments were carried out to evaluate
if the arachidonic acid concentrations detected in serum
of patients with AFLP could inﬂuence hepatocyte function. For these, Chang liver cells, which had been used
earlier to study oxidative stress39 were used as a model.
Treatment of hepatocytes with various concentrations of
arachidonic acid from 20-100 M did not result in lactate
dehydrogenase release (data not shown), suggesting the
absence of necrotic cell death. However, arachidonic acid
induced an increase in caspase-3 activity in a dose-dependent manner (Fig. 6C) in hepatocytes, indicative of induction of apoptosis. Caspase-3 activity in the presence of
80 M arachidonic acid (the concentration seen in AFLP
patient serum) was signiﬁcantly increased from that at 20
M (the concentration seen in pregnant controls), suggesting that the concentration of arachidonic acid seen in
serum from patients with AFLP is capable of inducing
apoptosis in hepatocytes.
Mitochondrial damage has been suggested to play an
important role in arachidonic acid induced toxicity,40 and
mitochondrial free radical generation has been implicated
in the apoptotic cascade. To determine if mitochondria
played a role in apoptosis in hepatocytes induced by arachidonic acid, experiments were conducted with dihydrorhodamine, which has been used to detect mitochondrial free radical generation.41 Treatment of Chang
liver cells with arachidonic acid resulted in a dose-dependent increase in DHR ﬂuorescence which was punctate,
indicating a mitochondrial origin (Fig. 7A). Again, spectroﬂuorimetric quantitation indicated that exposure to 80
M arachidonic acid resulted in a signiﬁcant increase in
DHR ﬂuorescence when compared to exposure to 20 M
(Fig. 7B).
Acute fatty liver of pregnancy is characterized by microvesicular steatosis in the mother’s liver, and we next
examined if the increased arachidonic acid in serum could
result in steatosis. Nile red staining of lipids has been used
as an indicator of steatosis in cell culture,42 and exposure
of hepatocytes to 40 M arachidonic acid for 72 hours
resulted in a signiﬁcant increase in Nile red staining when
compared to controls (Fig. 7C). The lipid accumulation
was also punctate, with cell nuclei in the center, similar to
accumulation seen in microvesicular steatosis.
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Discussion
Acute fatty liver of pregnancy is a sudden catastrophic
illness occurring almost exclusively in the third trimester;
the disorder carries signiﬁcant perinatal and maternal
mortality and requires early diagnosis and intervention to
prevent maternal and fetal death.43 Early recognition of
AFLP and immediate termination of pregnancy is the key
to improving maternal survival in this devastating disease.44 This then led to us focusing on the role of the
placenta in development of maternal liver disease. Placental mitochondria have been shown to be a source of oxygen free radicals in patients with preeclampsia,17 a
condition which has been suggested to be a component of
the spectrum of AFLP.16 Our data demonstrates that placental mitochondrial function is compromised in patients
with AFLP, accompanied by oxidative stress in the organelle. In support of our ﬁndings, studies have shown
that placental mitochondrial generation of superoxide
could be an important source of oxidative stress in preeclampsia, leading to increased lipid peroxidation in mitochondria.17,45
In the event of compromised mitochondrial function,
oxidation of fatty acids is channeled to peroxisomal ␤-oxidation, which, unlike mitochondrial fatty acid oxidation,
generates hydrogen peroxide.18 In addition, omega oxida-
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tion of fatty acids in microsomes form long-chain dicarboxylic acids which are also a substrate for peroxisomal
fatty acyl coenzyme A oxidase.46 The dicarboxylic acids
formed can result in increased production of hydrogen
peroxide,47 which can undergo the Fenton’s reaction in
the presence of heavy metals to form the highly reactive
hydroxyl radicals and result in oxidative tissue damage.
This seems to be occurring in placenta from patients with
AFLP, because oxidative stress was evident in peroxisomes
in addition to mitochondria. A reduced thiol content and
decrease in antioxidant enzymes accompanied by increased lipid peroxidation has been shown in placentas
from patients with preeclampsia.48 The increased levels of
arachidonic acid and other fatty acids seen in placenta
from patients with AFLP raise the possibility that these
changes could be due to compromised fatty acid oxidation, but further experiments will be needed to conﬁrm
this.
So how do these changes in the placenta affect the
maternal liver? The data indicates signiﬁcant increase in
oxidative and nitrosative stress parameters in the serum
and decrease in antioxidant levels. Nitric oxide is now
recognized as an important molecule with wide-ranging
physiological functions. The simultaneous presence of oxygen free radicals and nitric oxide can result in formation
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function? Arachidonic acid can induce production of reactive oxygen species from mitochondria,53 and has been
shown to decrease mitochondrial membrane potential,
increase lipid peroxidation, and decrease cell viability in
HepG2 cells.54 This toxicity appears to be apoptotic in
nature and was prevented by overexpression of bcl-2.37
Our data with hepatocytes in culture clearly indicate that
levels of arachidonic acid in patient serum can induce
mitochondrial reactive oxygen species production and apoptotic cell death in hepatocytes, resulting in apoptosis.
This then suggests that increased arachidonic acid and
oxidative stress in serum due to placental mitochondrial
dysfunction may perhaps cause hepatocyte damage in the
maternal liver in patients with AFLP.

Fig. 6. Measurement of free fatty acids in serum. (A) Arachidonic acid
and (B) palmitic acid from patients with AFLP (n ⫽ 7) as compared with
healthy pregnant controls (n ⫽ 10). The assays were done as described
in the text. Each value represents mean ⫾ SD. *P ⬍ 0.05, when
compared to control. (C) Caspase-3 activity in hepatocytes treated with
arachidonic acid. Conﬂuent cells were treated with varying concentrations
of arachidonic acid for 3 hours, after which cells were lysed and
caspase-3 activity was determined (n ⫽ 3). Data is expressed as
mean ⫾ SD. *P ⬍ 0.05, when compared to control; #P ⬍ 0.05, when
compared to 20 M.

of reactive nitrogen species such as peroxynitrite,49 which
are highly damaging. Supplementation with antioxidants
such as vitamin C and E has been shown to be beneﬁcial
in the prevention of preeclampsia,50 suggesting that this is
probably a global phenomenon.
In parallel to increased oxidative stress in serum, levels
of fatty acids such as arachidonic acid were also found to
be increased. Although none of the patients with AFLP
were obese and all were from the same socioeconomic
status, we cannot rule out the role of nutrition in modulating fatty acid levels. However, the increased levels of
free fatty acids in the liver of AFLP patients has been
suggested to be a mechanism of toxicity,51 and it has also
been demonstrated that exposure of hepatocytes to arachidonic acid or other polyunsaturated fatty acids results
in lipid peroxidation and cellular toxicity.37,52 In that
case, could the elevated levels of arachidonic acid in maternal serum play a role in compromising hepatocyte

Fig. 7. (A,B) Mitochondrial reactive oxygen species generation in
hepatocytes in response to arachidonic acid. Cells were treated with
varying concentrations of arachidonic acid for 3 hours, following which
cells were (A) subjected to live-cell imaging or (B) lysed and ﬂuorescence
measured on a spectroﬂuorimeter. The inset in (A) depicts the ﬁeld at a
higher magniﬁcation to show punctate nature of staining. In (B), data is
expressed as mean ⫾ SD (n ⫽ 3). *P ⬍ 0.05, when compared to
control; #P ⬍ 0.05, when compared to 20 M. (C) Lipid accumulation
in hepatocytes after exposure to arachidonic acid: Hepatocytes in culture
were treated with 20 and 40 M arachidonic acid for 72 hours, following
which cells were stained with Nile red and subjected to live-cell imaging
as mentioned in the Patients and Methods section (n ⫽ 3).
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A distinctive histological feature in the liver of patients
with AFLP is microvesicular steatosis, where accumulation of triglyceride occurs as small, uniform fat droplets
dispersed throughout the hepatocyte.55 The data so far
indicate that concentrations of arachidonic acid seen in
serum from AFLP patients could induce hepatocyte damage; and the data from Nile red staining, which detects
triglycerides,56 suggest that exposure to arachidonic acid
concentrations lower than those seen in patients with
AFLP over 3 days can result in an increased lipid accumulation in hepatocytes in culture similar to microvesicular
steatosis in the liver.
In conclusion, this study has shown that in placenta of
patients with AFLP, compromised mitochondrial function probably results in shunting of fatty acid oxidation to
peroxisomes and generation of oxidative stress in these
organelles. Free radical production and accumulation of
fatty acids in the placenta is accompanied by oxidative
stress in serum along with elevated levels of free fatty acids
such as arachidonic acid. Exposure of maternal hepatocytes to this milieu probably plays an important role in
mitochondrial dysfunction leading to acute liver failure.
Experiments to conﬁrm compromised fatty acid oxidation in placental mitochondria of AFLP patients and to
determine levels of fatty acids in patient serum after delivery are currently underway.
Acknowledgment: S.K.N. is a Senior Research Fellow
of the Indian Council of Medical Research.
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